Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
GET4 antisense RNA 1 (GET4-AS1) is a long non-coding RNA (lncRNA) transcribed from the genomic region antisense to the GET4 gene[1]. Like other antisense lncRNAs, GET4-AS1 does not encode a protein but may exert regulatory effects on the expression of its sense gene (GET4) by mechanisms such as modulating RNA stability, transcriptional interference, or recruiting epigenetic modifiers[2][4][5][6]. Antisense lncRNAs can influence biological processes including cell proliferation, cell death, or responses to cellular stress, through interactions with sense mRNAs or chromatin complexes[2][4][5][6]. There is currently no direct evidence that GET4-AS1 is a receptor, enzyme, transporter, or therapeutic target, nor are there documented disease roles, drug interactions, or well-established safety concerns related specifically to GET4-AS1 as of this search. Its main classification is as a regulatory lncRNA molecule, fitting within the broader class of natural antisense transcripts that function in gene regulation rather than direct therapeutic targeting[1][3][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on GET4 antisense RNA 1 (GET4-AS1).